
French pharmaceutical firm Sanofi said Friday that it will buy the US company Pluromed and push for widespread adoption of its FDA- and EU-approved cardiovascular surgery aid LeGoo. Financial details of the deal were not released. Pluromed, a medical device company located in the Boston suburb of Woburn, patented LeGoo, a polymer-based gel, to control bleeding during surgery. It replaces clamps or snares that can damage blood vessels, and is used as a temporary injectable plug that keeps surgical sites clear so surgeons can precisely place sutures. A Sanofi statement quoted Pluromed board member William Cohn as saying: \"I believe this technology will be widely adopted in cardiovascular surgery and perhaps in other fields in the future.\" Sanofi\'s acquisition of Pluromed is subject to \"customary closing conditions,\" the French group noted. Sanofi senior vice president Alison Lawton explained that \"the acquisition of Pluromed underscores Sanofi\'s commitment to strengthen its biosurgery portfolio.\" \"We are confident that Sanofi has the expertise and resources necessary to bring LeGoo to market and drive adoption,\" she added.
GMT 09:47 2018 Tuesday ,23 January
SAP unveils big push into French tech start-upsGMT 05:07 2018 Tuesday ,23 January
Noble Group shares surge 37 percent on buyout talksGMT 19:07 2018 Monday ,22 January
BAKS spent Dh225m on charity projects in 2017GMT 22:52 2018 Sunday ,21 January
French firm "recalls baby milk product"GMT 22:27 2018 Sunday ,21 January
US company plans funds that double bitcoin price movesGMT 21:23 2018 Sunday ,21 January
Pence starts Mideast tour in Egypt amid Arab angerGMT 08:54 2018 Saturday ,20 January
Million-euro bill for firm behind Paris bike-share chaosGMT 10:47 2018 Friday ,19 January
German chemical giant BASF sees 'significant' profit leap

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor